Avandia Found to Decrease After-Meal Triglycerides and Free Fatty Acid Concentrations


By: Daniel Trecroci

A Dutch study found that in people with type 2,the drug Avandia improved metabolism of largetriglyceride-rich lipoproteins and decreased after-meal free fatty acid metabolism concentrations.

An eight-week, double-blinded trial was performedin which 19 type 2s were administered Avandia indoses of 4 milligrams twice daily. While Avandiadid not change fasting triglyceride levels, it didsignificantly improve after-meal triglyceride levels.

In addition, Avandia decreased free fatty acid levels1 percent as compared with a placebo.

The researchers speculate that these findings mayhave clinical implications in that reduced after-meal free fatty acid concentrations may offercardiovascular risk reduction for type 2s.

Diabetes Care, April 2005



Diabetes Health Medical Disclaimer
The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.